Señales en vivo de 002038.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:04):

Stats
Volumen de hoy	12.92M
Volumen promedio	21.70M
Capitalización de mercado	8.86B
EPS	CNY0.000390 ( 2023-09-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-23
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	30.79
ATR14	CNY0.0100 (0.12%)

Volumen Correlación

Largo: -0.02 (neutral)

Corto: -0.56 (weak negative)

Signal:(56.553) Neutral

Beijing SL Pharmaceutical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing SL Pharmaceutical Correlación - Moneda/Commodity

0.22
( neutral )

-0.07
( neutral )

0.00
( neutral )

0.24
( neutral )

0.34
( neutral )

Beijing SL Pharmaceutical Finanzas

Annual	2023
Ingresos:	CNY1.01B
Beneficio Bruto:	CNY702.76M (69.70 %)
EPS:	CNY0.410

FY	2023
Ingresos:	CNY1.01B
Beneficio Bruto:	CNY702.76M (69.70 %)
EPS:	CNY0.410

FY	2022
Ingresos:	CNY1.05B
Beneficio Bruto:	CNY893.21M (85.05 %)
EPS:	CNY0.230

FY	2021
Ingresos:	CNY1.21B
Beneficio Bruto:	CNY1.03B (84.89 %)
EPS:	CNY0.410

Financial Reports:

No articles found.

Beijing SL Pharmaceutical

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.